Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Neurology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Clinical Trial ● Currently Recruiting Non-phase study NCT07368881

Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based Incentives

Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based Incentives — Recruiting • Non-phase study • Gastroenterology • NCT07368881.

📅 01 May 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
Phase
Non-phase study
NCT ID
NCT07368881
Start
2026-02-24
Completion
2026-06-30
ClinicaliQ Trial Snapshot
  • Fast Food Online Delivery Purchase Behaviour in the Presence and Absence of Price-based Incentives — Recruiting • Non-phase study • Gastroenterology • NCT07368881.
  • Removing price discounts from fast food delivery apps slightly reduced calorie selections, but effects were unclear and based on hypothetical choices only.

Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.

Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Consumption of out-of-home (OOH) food is associated with significantly greater energy and less-healthy nutrient (i.e. fats, salt and sugar) intake. The price of food is a key consideration of food choice, particularly for individuals of lower socioeconomic position (SEP). Little research to date has examined the causal effect of removing price-based incentives on purchasing behaviour in OOH food settings. One online randomised controlled trial explored the effect of removing three types of price-based incentives individually and in combination, on food choice through a virtual food delivery platform. This study found…

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
‘I used delivery apps to hide the shame of alcoholism’
Gastroenterology · BBC Health · 24 Apr 2026
Alcohol addiction can be masked through anonymous delivery services, making problematic drinking less visible to family, friends, and healthcare providers—a barrier to…
View brief →
Clinical Brief
‘Would I have made it to 60 if my cancer symptoms weren’t detected?’
Gastroenterology · BBC Health · 01 Apr 2026
I appreciate you sharing this article, but I'm unable to provide a meaningful summary as the content provided contains only a title…
View brief →
Clinical Brief
UKHSA and Stablepharma highlight breakthrough with fridge-free tetanus and diphtheria vaccine
Gastroenterology · UKHSA · 13 Mar 2026
Stablepharma has developed a thermostable tetanus and diphtheria vaccine requiring no cold-chain storage, addressing a critical logistical barrier to immunisation in resource-limited…
View brief →
Guideline
Irritable Bowel Syndrome in Adults: Diagnosis and Management (NICE CG61)
Gastroenterology · 27 Mar 2026
Offer structured dietary and lifestyle advice as first-line treatment, including consideration of a low FODMAP diet if standard measures are insufficient, before…
View guideline →
Drug Science
The IL-17/IL-23 Axis
Dermatology · 04 Apr 2026
The IL-17/IL-23 Axis is a clinically relevant Drug Science explainer. The IL-23/IL-17 axis is a central driver of immune-mediated inflammatory disease. IL-23,…
Explore mechanism →
Guideline
Cirrhosis in Over 16s: Assessment and Management (NICE NG50)
Gastroenterology · 27 Mar 2026
Perform upper endoscopy to screen all cirrhosis patients for oesophageal varices; if present, offer variceal band ligation and initiate non-selective beta-blockers (propranolol…
View guideline →